|
Consensus recommendations |
Grade |
|
HCV qualitative PCR should be performed 12 weeks after cessation of DAA therapy. |
A1 |
|
People with cirrhosis should continue in long-term variceal and HCC surveillance programs. |
A1 |
|
People with no cirrhosis who achieve SVR and normal liver function test results should be medically managed as individuals who have never had HCV infection. |
B1 |
|
People with persistently abnormal liver function test results after SVR should undergo further assessment and monitoring for alternative causes of liver disease. |
A1 |
|
People with ongoing risk factors for the transmission of HCV infection should have at least annual HCV RNA testing performed. |
B1 |